Stay updated on M2951 in SLE Phase II Clinical Trial
Sign up to get notified when there's something new on the M2951 in SLE Phase II Clinical Trial page.

Latest updates to the M2951 in SLE Phase II Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA site-wide NIH notice describes a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2, while the study record remains behind a 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedExternal links and study documents were removed from the page, including the US Medical Information website, Trial Awareness and Transparency page, PDFs such as the Statistical Analysis Plan and Study Protocol, and sponsor/collaborator details. This reduces on-page access to primary trial documents and related organizational information used to assess the study's methodology and governance.SummaryDifference19%

- Check51 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated revision of the study documents on the page.SummaryDifference0.0%

- Check65 days agoChange DetectedThe system revision is updated from v3.6.5 to v3.6.6, indicating a small backend update to the platform hosting the study details. This update does not alter the study content or visible information on the page.SummaryDifference0.0%

Stay in the know with updates to M2951 in SLE Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M2951 in SLE Phase II Clinical Trial page.